Biotex, Inc.
Houston, TX · Medtech · Private
A surgically implantable device that encases arteriovenous fistulas to protect access veins and guide hemodialysis needle placement
- Grants
- $11M
- 11 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1.4M
- 6 awards · NASA, Environmental Prot, Health and Human S
- #270 of 4531 in medtech
- Patents
- 18
- 0 granted · 18 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200420062008201020122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | National Aeronautics and Space Administration · 4200143028 Monitoring Microbes In The Spacecraft | $70,000 | |
| Federal contract | Environmental Protection Agency · Small Business Innovation Research - Phase I | $69,961 | |
| Federal contract | Department of Health and Human Services · SBIR Topic 257, "instruments And Devices That Preserve Molecular Profiles In Tumors" | $249,792 | |
| Federal contract | Department of Health and Human Services · TAS::75 0849::TAS Topic 288 Development Of Alternative Affinity Capture Reagents For Cancer Proteomics Research | $149,800 | |
| Federal contract | Department of Health and Human Services · SBIR Topic 294 Phase 1 - Development Of Glycosylation - Specific Research | $149,919 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Other Functions SBIR Phase II, Topic 22, "development Of Alternative Affinity Capture Reagents For Cancer Proteomics Research" | $749,996 | |
| Federal grant | Department of Health and Human Services · Phase II · Portable nanofluidic aptamer-SERS instrument for measurement of chemical exposure | $714,230 | |
| Federal grant | Department of Health and Human Services · Phase II · Portable nanofluidic aptamer-SERS instrument for measurement of chemical exposure | $704,977 | |
| Federal grant | Department of Health and Human Services · Phase I · Improving Repair of Female Congenital and Reproductive Anomalies | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Improved Esophageal Safety in Atrial Fibrillation Elimination | $226,166 | |
| Federal grant | Department of Health and Human Services · Phase II · Improved Esophageal Safety in Atrial Fibrillation Elimination | $1,189,793 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving Repair of Female Congenital and Reproductive Anomalies | $1,486,212 | |
| Federal grant | Department of Health and Human Services · Phase II · Improved Esophageal Safety in Atrial Fibrillation Elimination | $615,943 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel 3-D Printed Implant for Improved Hemodialysis Access | $2,153,319 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving Repair of Female Congenital and Reproductive Anomalies | $814,001 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel 3-D Printed Implant for Improved Hemodialysis Access | $1,358,290 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel wearable rotating magnetic field therapy device targeting treatment of brain cancers | $1,296,385 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 267 | APPLIED BIOPHYSICS, INC. | $1.4M | — |
| 268 | Detect | $1.4M | — |
| 269 | Coapt LLC | $1.4M | — |
| 270 | Biotex, Inc. | $1.4M | — |
| 271 | ADVANCED SILICON GROUP, INC. | $1.4M | $1.0M |
| 272 | Olifant Medical, Inc. | $1.4M | — |
| 273 | TISSUE TESTING TECHNOLOGIES LLC | $1.4M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Guidewire Holder And Methods Thereofapplication
- Methods And Devices For Trocar Placementapplication
- Methods For Molecular Detectionapplication
- Nucleic Acid Ligands To LL37application
- Nucleic Acid Ligands To LL37application
- Methods And Devices For Trocar Placementapplication
- Methods And Devices For Pathogen Detectionapplication
- Methods And Devices For Trocar Placementapplication
- Esophageal Probes And Methodsapplication
- Guidewire Holder And Methods Thereofapplication
- Methods For Simultaneous Generation Of Functional Ligandsapplication
- Methods For Molecular Detectionapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.